Cargando…
Future medical and non-medical costs and their impact on the cost-effectiveness of life-prolonging interventions: a comparison of five European countries
When healthcare interventions prolong life, people consume medical and non-medical goods during the years of life they gain. It has been argued that the costs for medical consumption should be included in cost-effectiveness analyses from both a healthcare and societal perspective, and the costs for...
Autores principales: | Mokri, Hamraz, Kvamme, Ingelin, de Vries, Linda, Versteegh, Matthijs, van Baal, Pieter |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10198844/ https://www.ncbi.nlm.nih.gov/pubmed/35925501 http://dx.doi.org/10.1007/s10198-022-01501-6 |
Ejemplares similares
-
Future Costs in Cost-Effectiveness Analyses: Past, Present, Future
por: de Vries, Linda M., et al.
Publicado: (2018) -
The Value of Health in a Cost-Effectiveness Analysis: Theory Versus Practice
por: Wouterse, Bram, et al.
Publicado: (2023) -
Distributional consequences of including survivor costs in economic evaluations
por: Kellerborg, Klas, et al.
Publicado: (2021) -
A cost‐effectiveness threshold based on the marginal returns of cardiovascular hospital spending
por: van Baal, Pieter, et al.
Publicado: (2018) -
The Relevance of Including Future Healthcare Costs in Cost-Effectiveness Threshold Calculations for the UK NHS
por: Perry-Duxbury, Megan, et al.
Publicado: (2021)